- Consortium Universities: University of Michigan, University of Washington, and University of Hawai’i
- Partner Universities: Peking University, China CDC, Chinese University of Hong Kong, University of Wuhan, University of Fudan
- Collaborating Research Grants: 23
- Training Grants: 3
- Research Themes: Cardiovascular Disease, Pulmonary Disease, Renal Disease, Liver Disease, and Vaccine Preventable Diseases.
International Institutional Partner Director:
Yangfeng Wu, M.D., Ph.D.
Professor of Epidemiology, Peking University School of Public Health
Executive Director for the George Institute for Global Health
Executive Associate Director of the Peking University Clinical Research Institute
Executive Board Member of the University of Michigan-Peking University Health Science Center Joint Institute for Clinical and Translational Research
Joe Kolars, MD
University of Michigan
University of Michigan
Amy Huang, M.D, MHSA
University of Michigan
Peking University Health Science Center:
Peking University Health Science Center (PUHSC) was initially established in 1903 as the Medical Clinic at the Royal Capital Higher Educational Institute. PUHSC is located in Beijing and offers a full range of courses for 9 specialties including basic medical sciences, clinical medicine, preventive medicine, stomatology, pharmaceutics, nursing, medical laboratory diagnosis, applied pharmacy, and biomedical English. PUHSC has 6 schools, namely, School of Basic Medical Sciences, School of Pharmaceutical Sciences, School of Public Health, School of Nursing, School of Stomatology, and school of Foundation Education. PHUSC has 8 affiliated hospitals: Peking University First Hospital, Peking University People’s Hospital, Peking University Third Hospital, Peking University Dental Hospital, Peking University Mental Health hospital, Peking University Cancer Hospital, Peking University Shenzhen Hospital and Peking University Shougang Hospital. PUHSC has 2 national key laboratory, 12 ministry-level key laboratories, 38 joint research centers, and 19 research institutes at university level.
Joint Institute for Clinical and Translational Research:
In 2010, the Joint Institute for Clinical and Translational Research (JI) was established between the University of Michigan Medical School and Peking University Health Science Center. This Institute has been capitalized with $14 million USD in matching contributions from both institutions for collaborative grants and supporting cores. The success of the JI will be measured in the ability to execute translational and clinical research studies in the U.S. and China on diseases relative to both countries. Specifically, information from pilot studies funded by the JI will be leveraged for extramural funding from the U.S. and Chinese governmental agencies as well as philanthropy. To date, six pilot studies have been initiated with another two planned for later this year. The projects have a co-lead at Peking University Health Science Center and one at the University of Michigan Medical School who is an NIH funded investigator. The focus of the three programs are lung disease (i.e. the influence of the microbiome on COPD and lung cancer), liver disease (i.e. hepatitis C, hepatoma, fatty liver disease), and cardiovascular disease (i.e. genetics of hypertension, HDL, and coronary artery disease). In addition to these three programs, three cores have been established: a biomedical informatics/biorepository core, a human protection/IRB core, and a science of collaboration core. Trainee and faculty exchanges have been an active component of the JI.
The University of Michigan has a long history of scholarship with China that dates back over 100 years. This is particularly true of the health science schools. For example, 22 of the Departments with the medical school are in active collaboration with 31 different medical schools in China. A recent PubMed analysis documents 481 papers with a first author in a Chinese medical school and a co-author from the University of Michigan Medical School. Similarly, the School of Public Health has a diverse set of initiatives in the area of vaccine delivery and environment health (e.g. lead toxicity).
University of Wuhan & University of Fudan:
The University of Hawaii has active education and research programs in China. A unique exchange program between the UH Office of Public Health Studies (UH-OPHS) and these most prestigious Schools of Public Health in China, is helping to foster groundbreaking research on a variety of public health and environmental science topics, such as environmental impacts of the Three Gorges Dam project, sexual behavior in Chinese college students, stress in the workplace and environmental health. The exchange program, which started in 2007, provides an opportunity for graduate students from the three institutions to perform research either in Hawaii or China two or three times a year. More than 50% of faculty members from UH-OPHS have travelled in China to teach or conduct research. Yuanan Lu, a professor of environmental health, and Jay Maddock, director of UH-OPHS, co-founded this program, which now has a long waiting list of outstanding candidates.